Wednesday, August 31, 2022

Grand Rounds

11:00 AM to 12:00 PM


CME credit available, click here

Attendance must be registered within 6 months of attendance to be awarded credit.

Recorded archives of live activities are considered enduring materials.

Viewing of a recorded session is for reference only, no CME credit can be claimed.

Join us

“Health Equity and Racial Disparities in MS Outcomes"

Dr. Annette Langer-Gould

Annette Langer-Gould, MD, PhD is the Regional Lead for Clinical and Translational Neuroscience for the Southern California Permanente Medical Group and practicing multiple sclerosis (MS) specialist at Los Angeles Medical Center. In her current role, she leads a team in Kaiser Permanente that develops, implements, and evaluates programs to provide high quality affordable care for individuals with MS, migraine, and other neurological diseases. She is a graduate of the University of Pittsburgh School of Medicine after which she completed her residency, neuroimmunology post-doctoral fellowship and PhD in epidemiology at Stanford University. She developed expertise in Specialty Pharmaceuticals as Assistant Medical Director at Roche/Genentech. She has been studying different aspects of MS susceptibility and prognosis for over 20 years. Dr. Langer-Gould’s epidemiologic research focuses on the interplay between race/ethnicity and modifiable factors including health care access and utilization, vitamin D and sun exposure in determining MS susceptibility and prognosis. In collaboration with the Swedish MS Registry, she is also studying the comparative effectiveness and safety of rituximab and other MS treatments. She has received grant support and awards from the National Institutes of Health, Patient Centered Outcomes Research Institute, and the National MS Society. She has served on committees and advisory panels for the National Institutes of Health, Institute of Medicine, American Academy of Neurology, and the National MS Society. She currently serves as a voting member on the California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review.